201 related articles for article (PubMed ID: 38250376)
1. Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma.
Bataille Backer P; Adekiya TA; Kim Y; Reid TR; Thomas M; Adesina SK
ACS Omega; 2024 Jan; 9(2):2615-2628. PubMed ID: 38250376
[TBL] [Abstract][Full Text] [Related]
2. New Transferrin Receptor-Targeted Peptide-Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity.
Yu J; Mao X; Yang X; Zhao G; Li S
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675578
[TBL] [Abstract][Full Text] [Related]
3. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
[TBL] [Abstract][Full Text] [Related]
4. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy.
Mojarad-Jabali S; Farshbaf M; Hemmati S; Sarfraz M; Motasadizadeh H; Shahbazi Mojarrad J; Atyabi F; Zakeri-Milani P; Valizadeh H
Int J Pharm; 2022 Feb; 613():121395. PubMed ID: 34933080
[TBL] [Abstract][Full Text] [Related]
6. Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review.
Kawak P; Sawaftah NMA; Pitt WG; Husseini GA
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686065
[TBL] [Abstract][Full Text] [Related]
7. Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate.
Li S; Zhao H; Mao X; Fan Y; Liang X; Wang R; Xiao L; Wang J; Liu Q; Zhao G
Pharm Res; 2019 Oct; 36(12):168. PubMed ID: 31654226
[TBL] [Abstract][Full Text] [Related]
8. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
9. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.
Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123
[TBL] [Abstract][Full Text] [Related]
10. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.
Tang L; Zhang R; Wang Y; Zhang X; Yang Y; Zhao B; Yang L
Acta Biomater; 2023 Jan; 155():521-537. PubMed ID: 36384220
[TBL] [Abstract][Full Text] [Related]
11. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme.
Sun P; Xiao Y; Di Q; Ma W; Ma X; Wang Q; Chen W
Int J Nanomedicine; 2020; 15():6673-6688. PubMed ID: 32982226
[TBL] [Abstract][Full Text] [Related]
12. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes.
Kim G; Kim M; Lee Y; Byun JW; Hwang DW; Lee M
J Control Release; 2020 Jan; 317():273-281. PubMed ID: 31730913
[TBL] [Abstract][Full Text] [Related]
14. An epirubicin-peptide conjugate with anticancer activity is dependent upon the expression level of the surface transferrin receptor.
Yang J; Yang Q; Xu L; Lou J; Dong Z
Mol Med Rep; 2017 Jan; 15(1):323-330. PubMed ID: 27959443
[TBL] [Abstract][Full Text] [Related]
15. In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.
Wängler C; Nada D; Höfner G; Maschauer S; Wängler B; Schneider S; Schirrmacher E; Wanner KT; Schirrmacher R; Prante O
Mol Imaging Biol; 2011 Apr; 13(2):332-41. PubMed ID: 20473573
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
17. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.
Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437
[TBL] [Abstract][Full Text] [Related]
18. Targeted Glioblastoma Treatment via Synthesis and Functionalization of Gold Nanoparticles With De Novo-Engineered Transferrin-Like Peptides: Protocol for a Novel Method.
Müller Fiedler A; Medeiros M; Fiedler HD
JMIR Res Protoc; 2023 Aug; 12():e49417. PubMed ID: 37531222
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy.
Riaz MK; Zhang X; Wong KH; Chen H; Liu Q; Chen X; Zhang G; Lu A; Yang Z
Int J Nanomedicine; 2019; 14():2879-2902. PubMed ID: 31118613
[No Abstract] [Full Text] [Related]
20. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
